The Prevalence of Anticitrullinated Protein Antibodies in Older Poles-Results from a Population-Based PolSenior Study

Int J Environ Res Public Health. 2022 Oct 31;19(21):14216. doi: 10.3390/ijerph192114216.

Abstract

Little is known about the occurrence of antibodies in older subjects. We analyzed the prevalence of anticitrullinated protein antibodies (anti-CCP) in a representative cohort of Polish older adults, participants of PolSenior substudy. Randomly selected 1537 serum samples of community-dwelling participants aged 65 and over. Questionnaires were completed by qualified interviewers and laboratory assessments served as a database for this analysis. The frequency of anti-CCP seropositivity (N = 50) was estimated at 3.25% (95% CI: 2.45-4.30%), being higher among women-4.05% (2.83-5.73%) than men-2.41% (1.48-3.86%). The frequency of anti-CCP seropositivity was decreasing with age from 4.29% in aged 65-74 years and 4.07% in 70-84 years to 1.50% in aged 85 years or above (p < 0.05). Hypoalbuminemia, inflammatory status (C-reactive protein >10 mg/dL or interleukin-6 ≥10 pg/mL), and female gender were associated with increased, while age ≥85 years with decreased risk of seropositivity. Multivariable logistic regression revealed that hypoalbuminemia, inflammatory status, and age ≥85 years were independently associated factors of anti-CCP seropositivity. The decreased frequency of anti-CCP seropositivity in the oldest old suggests shorter survival of the seropositive individuals who developed rheumatoid arthritis. It seems that low symptomatic RA remains frequently undiagnosed in older subjects.

Keywords: ACPA; anti-CPP prevalence; anticitrullinated protein antibodies; older adults; rheumatoid arthritis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Citrullinated Protein Antibodies*
  • Autoantibodies
  • Female
  • Humans
  • Hypoalbuminemia*
  • Male
  • Peptides, Cyclic
  • Prevalence

Substances

  • Anti-Citrullinated Protein Antibodies
  • Peptides, Cyclic
  • Autoantibodies

Grants and funding

This research was supported by the Ministry of Science and Higher Education [PBZ-MEIN9/2/2006] and a grant from the Medical University of Silesia in Katowice (PCN-1-116/N/2/Z).